GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
3254.0000 -55.00 (-1.66%)
NSE Jul 10, 2025 14:59 PM
Volume: 38,560
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
05 Aug 2024
3254.00
-1.66%
buy
by ICICI Securities Limited
Target: 2640 | Target met
ICICI Securities Limited
GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.
 
GlaxoSmithKline Pharmaceuticals Ltd. is trading above its 200 day SMA of 2655.1
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market trades lower, SBI plans a Rs 25,000 crore share sale via a QIP
Trendlyne Marketwatch | 10 Jul 2025, 02:49PM
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
The Baseline | 10 Jul 2025, 12:14PM
All in the family: Bajaj, Murugappa, Mahindra & Tata Group stocks outpace the benchmark
The Baseline | 09 Jul 2025, 04:24PM